Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China · Delayed Price · Currency is CNY 21.76
+0.09 (0.42%)
Jan 23, 2026, 11:29 AM CST
Nanjing Vazyme Biotech Market Cap
Nanjing Vazyme Biotech has a market cap or net worth of 8.62 billion as of January 22, 2026. Its market cap has decreased by -6.04% in one year.
Market Cap
8.62B
Enterprise Value
6.76B
Revenue
1.34B
Ranking
n/a
PE Ratio
n/a
Stock Price
21.76
Market Cap Chart
Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 8.62B, a decrease of -74.75%. That is a compound annual growth rate of -28.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 8.62B | 8.24% |
| Dec 31, 2025 | 7.96B | -9.63% |
| Dec 31, 2024 | 8.81B | -31.21% |
| Dec 29, 2023 | 12.81B | -39.74% |
| Dec 30, 2022 | 21.26B | -49.87% |
| Dec 31, 2021 | 42.40B | 24.19% |
| Nov 15, 2021 | 34.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 406.83B |
| WuXi AppTec | 305.26B |
| Shenzhen Mindray Bio-Medical Electronics | 242.11B |
| Sichuan Biokin Pharmaceutical | 126.75B |
| Shanghai United Imaging Healthcare | 110.18B |
| Aier Eye Hospital Group | 105.32B |
| Zhangzhou Pientzehuang Pharmaceutical., | 101.25B |
| Yunnan Baiyao Group Co.,Ltd | 100.31B |